eureKARE
eureKARE invests in synthetic biology startups across Europe, from early to later stages, via biotech studios bridging academia and industry to drive health and environmental innovation.
Funding Stage: Pre-Seed / Seed, Series A/B
Investor type: VC Firm
Investment Areas: Biotechnology, Finance, Venture Capital
Country: France
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.